Contact
Please use this form to send email to PR contact of this press release:
Genkyotex Conference Call for Post-Hoc Analysis of Setanaxib (GKT831) PBC Ph2 Trial and Business Update
TO:
Please use this form to send email to PR contact of this press release:
Genkyotex Conference Call for Post-Hoc Analysis of Setanaxib (GKT831) PBC Ph2 Trial and Business Update
TO: